Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (5): 686-690    DOI: 10.12891/ceog3536.2017
Original Research Previous articles | Next articles
Protective role of adrenomedullin in heterotopic ovarian transplant
E. Erdemoglu1, *(), S.G. Gürgen2, E. Erdemoglu3, K. Kürşat Bozkurt4, E. Oz Oyar5
1 Department of Gynecology and Obstetrics, Womens and Children Hospital, Isparta, Turkey
2 Department of Histology and Embryology, Celal Bayar University Medical Faculty, Manisa, Turkey
3 Department of Gynecologic Oncology, Suleyman Demirel University Medical Faculty, Isparta, Turkey
4 Department of Pathology, SuleymanDemirel University Medical Faculty, Isparta, Turkey
5 Department of Physiology, Katip Celebi University Medical Faculty, Izmir, Turkey
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of investigation: To study adrenomedullin (ADM) in preventing ischemia and morphological changes in heterotopically transplanted ovary. Materials and Methods: Forty female Sprague-Dawley rats were divided into four groups. In groups 1 and 2 each ovary was transplanted to the corresponding inguinal region by heterotopic transplantation. In groups 3 and 4, ovaries were left intact without transplantation. Treatment was injected to left inguinal region. ADM was given in groups 1 and 3 and placebo was given in groups 2 and 4. Left ovaries showing local treatment effect in heterotopic transplantation was designated as A (1A, 2A, 3A, and 4A), right ovaries showing systemic treatment effect were designated as (1B, 2B,3B, and 4B). Main outcome measures were ischemia, follicle count, and CD 31 expression. Results: Ovaries treated with local ADM (group 1A) were in consonance with normal rat ovaries. The ovaries of rats in group 1B and placebo treated transplant group (groups 2A, 2B) exhibited varying effects of ischemia. The mean follicle numbers in groups 1A, 1B, 2A, 2B were 28 ± 3.3, 16.8 ± 2.5, 17.7 ± 2.1, 16.4 ± 2.9, respectively. The mean follicle number in groups 3A, 3B, 4A, and 4B were 27.7 ± 2.0, 28.3 ± 2.2, 28.3 ± 2.2, 27.8 ± 1.9, respectively. Corpus luteum number and CD31 expression was found to be significantly higher in group 1A. Conclusion: Subcutaneous injection of ADM to heterotopic ovarian graft site causes vasodilatation and increases angiogenesis and may protect ovarian graft against hypoxic damage.
Key words:  Heterotopic transplantation      Adrenomedullin      Ovary      Ischemia      CD 31     
Published:  10 October 2017     
*Corresponding Author(s):  E. ERDEMOGLU     E-mail:  ebru.md@hotmail.com

Cite this article: 

E. Erdemoglu, S.G. Gürgen, E. Erdemoglu, K. Kürşat Bozkurt, E. Oz Oyar. Protective role of adrenomedullin in heterotopic ovarian transplant. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 686-690.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3536.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I5/686

[1] J. Dun, X. Wang, J. Yang, J. Xu. Clinical practice guidelines on polycystic ovary syndrome: a systematic review and comparative meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 465-471.
[2] S. Lane, A. Newman, M. Vergine, K. Allan, F. Usifo, C.C. Yeoh, S. Rahimi. Pulmonary-derived papillary adenomatoid proliferation arising in ovarian mature cystic teratoma[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 611-613.
[3] Xiao-Tao Huang, Shao-Rong Liang, Lu Wang. Acupuncture combined with Chinese and western medicine in the treatment of polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 396-400.
[4] A. M. Maysara, A. T. Nassar, H. K. Jubran. The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 272-276.
[5] Hue HJ, Kim SK, Choi JY, Suh DH, Kim KD, No JH, Lee JR, Jee BC, Kim YB, Jeon HW. Previous ovarian surgery increases the risk of tubal factor infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 84-88.
[6] N.C. Llarena, A.B. Shah, C. Biscotti, T. Falcone, M.J. Uy-Kroh. Thermal injury to the ovary and uterus in a porcine model: a comparison of four energy sources[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 964-968.
[7] H.M.G. Youssef, E.S. Marei, L.A. Rashed. Long non-coding RNA steroid receptor activator in polycystic ovary syndrome: possible association with metabolic syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 757-762.
[8] T. Toporcer, T. Grendel, I. Uhrinová, S.F. Iannaccone, A. Grendelová, F. Sabol, J. Belák, S. Toporcerová. Effect of low molecular weight heparin on autotransplantation efficacy of ovarian tissues in rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 542-548.
[9] M.H. Vieira de Melo, M.T. Albuquerque Barbosa Cabral Micussi, R. Dias de Medeiros, R. Ney Cobucci, T.M. de Oliveira Maranhão, A.K. Gonçalves. Pelvic floor muscle thickness in women with polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 813-816.
[10] Hui-lan Wang, Xia Xu, Zhi-qun Zheng. The expression of Nuclear Factor-κB in a rat model of polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 276-279.
[11] C. Togrul, A.C. Dogan, E. Baser, M. Dogan, A. Albayrak, M. Caglar, T. Gungor, G. Ozturk, E. Fadillioglu, T. Delibasi. The effects of sildenafil and tadalafil on ischemia–reperfusion injury in rat ovarian torsion model[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 535-539.
[12] A. Eser, D. Hizli, M. Namuslu, H. Haltas, N. Kosus, A. Kosus, H. Kafali. Protective effect of curcumin on ovarian reserve in a rat ischemia model: an experimental study[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 453-457.
[13] M. Bawahab, G. Alshumrani, M. Al-Shraim, M. Eskandar, A. Shaamash. Isolated left descended inguinal ovary with ipsilateral ectopic pelvic kidney: a case report and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 483-486.
No Suggested Reading articles found!